raloxifene hydrochloride has been researched along with Insulin Resistance in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anaya-Prado, R; Grover-Páez, F; Zavalza-Gómez, AB | 1 |
Lovre, D; Mauvais-Jarvis, F; Xu, B | 1 |
Colao, A; Lombardi, G; Mastrantonio, P; Nappi, C; Orio, F; Palomba, S; Russo, T; Sammartino, A; Sbano, FM; Zullo, F | 1 |
Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V | 1 |
Ando, H; Kaneko, S; Komura, T; Matsushita, E; Minato, H; Shimizu, A; Takamura, T; Zen, Y | 1 |
Gilkison, C; Nagamani, M; Sepilian, V; Szymajda, A; Urban, RJ | 1 |
Fajardo, ME; Malacara, JM; Nava, LE | 1 |
Anderson, PW; Andersson, B; Bengtsson, BA; Holm, G; Johannsson, G; Mason, T; Pavo, I; Sashegyi, A | 1 |
1 review(s) available for raloxifene hydrochloride and Insulin Resistance
Article | Year |
---|---|
The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.
Topics: Aging; Animals; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Humans; Indoles; Insulin Resistance; Models, Biological; Obesity; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2017 |
5 trial(s) available for raloxifene hydrochloride and Insulin Resistance
Article | Year |
---|---|
Raloxifene modifies the insulin sensitivity and lipid profile of postmenopausal insulin resistant women.
Topics: Adult; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Middle Aged; Placebos; Postmenopause; Prediabetic State; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2013 |
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene.
Topics: Adult; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Leiomyoma; Leuprolide; Lipids; Middle Aged; Placebos; Premenopause; Raloxifene Hydrochloride; Triglycerides; Uterine Neoplasms; Vitamin B 12 | 2004 |
Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women.
Topics: Blood Glucose; C-Peptide; Fasting; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Lipids; Liver; Middle Aged; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Reference Values; Selective Estrogen Receptor Modulators; Time Factors | 2008 |
Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens.
Topics: Chromans; Clomiphene; Estrogens; Feedback, Physiological; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hypoglycemic Agents; Insulin Resistance; Menopause; Metformin; Middle Aged; Obesity; Pregnancy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial.
Topics: Aged; Androgens; Blood Coagulation Factors; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Estrogen Antagonists; Female; Glucose Clamp Technique; Humans; Hyperandrogenism; Insulin Resistance; Insulin-Like Growth Factor I; Lipoproteins; Middle Aged; Postmenopause; Raloxifene Hydrochloride | 2002 |
2 other study(ies) available for raloxifene hydrochloride and Insulin Resistance
Article | Year |
---|---|
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone | 2005 |
Selective estrogen receptor modulator raloxifene-associated aggravation of nonalcoholic steatohepatitis.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Glucose Intolerance; Humans; Insulin Resistance; Liver; Liver Cirrhosis; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Severity of Illness Index | 2007 |